In Silico Preliminary Evaluation of Bioactive Compounds from Five Unani Drugs As Potential SARS-CoV-2 Inhibitors: IN SILICO EVIDENCE OF FIVE UNANI DRUGS AGAINST SARS-COV-2. IJTK 2024, 23 (3), 247-261. https://doi.org/10.56042/ijtk.v23i3.1412.